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TUBERCULOSIS (TB) is an important public health problem; it is essential to analyse its current epidemiological situation to understand the disease. According to the World Health Organization (WHO), there were 8.7 million new TB cases and 1.4 million deaths due to TB worldwide in 2011; the absolute number of TB cases has fallen since 2006, and incidence has decreased since 2002. The treatment success rate for new smearpositive pulmonary TB (PTB) cases was 87% in 2010. 1 The resurgence of TB in the 1980s shows how Mycobacterium tuberculosis can reappear if TB control and care are neglected. 2 As major steps forward are being achieved in public health, now is the time to continue with efforts to fi nd better diagnostic and S U M M A R Y treatment tools, and strategies aimed at permanently reducing TB rates worldwide. 3 The Regional Ministry of Health in Galicia, Spain, created the Galician Tuberculosis Prevention and Control Programme (GTPCP) at the end of 1994 to actively identify and monitor TB through its TB prevention and control units (TBU). 4 In accordance with the 4 December 1998 law on TB surveillance in Galicia, all medical professionals practising in Galicia are required to notify all TB cases, their follow-up and treatment outcomes, their contact tracing studies, and their follow-up and preventive treatment outcomes to the Tuberculosis Information System (TIS). Based on the epidemiological data of the TIS, detailed information is now available on the behaviour of TB.
The present study aims to analyse the impact of the GTPCP and evaluate the current epidemiological situation, its 16-year evolution (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) and the main characteristics of TB in Galicia, an area with an average level of incidence, 16 years after the GTPCP was created.
STUDY POPULATION AND METHODS
Galicia, an Autonomous Region in north-western Spain (area 29 574.4 km 2 , population 2 762 198, population density 94.5 inhabitants/km 2 ) is characterised by highly dispersed settlements, accounting for half of all the population centres in Spain (30 000 of a total of 60 000). The region is divided into seven major health districts, each of which has a TBU with medical and nursing staff and social workers. A retrospective descriptive observational study of the period from 1 January 1996 to 31 December 2011 was carried out in this setting.
This article describes the characteristics of new TB cases from 2011, while the tables and fi gures show the trends and characteristics for the entire period (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) .
TB epidemiological data in Galicia are obtained from the TIS, in which data are recorded from 1) passive case fi nding and 2) active search for undeclared cases, using existing records and documentation (from the microbiology, pathological anatomy and pharmacy departments, hospital discharge reports, information on acquired immune-defi ciency syndrome [AIDS], prison records and mortality rates), and review of the clinical records of presumed TB cases and patient interviews. European Centre for Disease Prevention and Control (ECDC; Stockholm, Sweden) case defi nitions were used for the study, 5 and WHO and European defi nitions were used for treatment outcomes. 6, 7 The following epidemiological, clinical and microbiological variables recorded by the GTPCP's epidemiological questionnaire include: age, sex, source of information, diagnostic delay, site of disease, radiological patterns, microbiological results (bacilloscopy, culture and drug susceptibility testing [DST]), associated risk factors (human immunodefi ciency virus [HIV] positive, drug use, immigration), directly observed treatment (DOT), treatment outcomes, and follow-up of contact tracing and results. Diagnostic delay was defi ned as the median number of days between symptom onset and treatment initiation.
DST was performed at the Galician Mycobacterial Reference Laboratory, which was created in 1998 and fulfi ls all quality control requirements established by the WHO for resistance studies; Galicia is included in the WHO/International Union Against Tuberculosis and Lung Disease Global Project on AntiTuberculosis Drug Resistance Surveillance. 8, 9 In this study, we present DST results since 2008, following changes in the computerised registration system. Multidrug-resistant TB (MDR-TB) cases are regularly reviewed by the Galician Committee for the Evaluation of the Control of Drug-Resistant Tuberculosis.
DOT is organised with the help of TBU social workers. In accordance with the provisions of the Organic Law 3/1986 dated 14 April 1986 on Special Public Health Measures, health authorities have the legal power to compel smear-positive patients to take their medications if necessary.
To calculate the TB incidence rate, we used population data obtained from the Galician Institute of Statistics as the denominators. A descriptive analysis was performed of the selected variables, using Epidat 4.0 (Xunta de Galicia, Santiago de Compostela, Spain; http://www.sergas.es/MostrarContidos_N3_T01. aspx?IdPaxina=62713). Age as a quantitative variable was characterised by mean and standard deviation (SD). The frequency distribution of the different variables and the percentage of cases with data on these variables was calculated.
RESULTS

Number of cases and tuberculosis incidence
The percentage of cases reported to the GTPCP of total recorded cases increased progressively up to the last 4 years of the study period, when it once again decreased (in 2011, 55.8% of cases were declared, while the remainder were obtained by active case fi nding). Information sources of undeclared cases and their evolution during this period are shown in Table 1 .
The number of new TB cases fell from 1994 in 1996 (72.9 cases per 100 000 population) to 689 in 2011 (24.6/100 000), an overall reduction of 65.4% and a mean annual decrease of 6.8%. All PTB cases and smear-positive PTB cases show similar trends ( Figure 1 ). Among patients aged <15 years, the number of cases fell from 118 (40.5/100 000) to 136 The International Journal of Tuberculosis and Lung Disease 46 (14.2/100 000), with a 61.0% reduction overall and a mean annual rate of 6.1%. In 2011, 49.8% of cases (n = 343) were aged 25-54 years, with the highest number of cases occurring in the older age groups throughout the period studied (in 1996, the highest proportion occurred in those aged 15-34 years); 62.3% (n = 429) were male; and the mean age was 46.7 years (SD 22.2): 77.3 in men and 45.8 in women. Figure 2 shows changes in the incidence rate in 1996 and 2011 by age group. Although in 1996 the highest incidence was in the 15-24 years age group (100.0/100 000), by 2011 it had changed to the over-70s age group (30.0/100 000); however, this rate is similar to that of the 25-34 and 35-44 year age groups.
Characteristics of new tuberculosis cases
Based on the WHO classifi cation, 52.1% (n = 359) of new TB cases were exclusively pulmonary, 37.6% (n = 259) were extra-pulmonary and the rest were both (n = 71, 10.3%). The main site of TB was pulmonary (n = 430, 62.4%), followed by pleural TB (n = 109, 15.8%) and TB of the peripheral nodes (n = 70, 10.2%), with other sites being less frequent.
The most common radiological pattern in PTB patients at the time of diagnosis was non-cavitary, in 62.3% (n = 268), while 33.5% (n = 144) had cavitary lesions and 4.0% (n = 17) had a normal chest X-ray (CXR). Results were unknown in the remaining 0.2% (n = 1). At the time of diagnosis, 50.7% (n = 218) of the 430 PTB cases were smear-positive, and 80.5% (n = 346/430) were confi rmed by culture. A defi nitive diagnosis was obtained for 36.3% (n = 94) of the 259 extra-pulmonary cases, which was lower than the mean for the period (40%).
During the period 2008-2011, 72 cases who had never previously been treated were resistant to isoniazid (3.9%, range 3.2-4.4) and 0.4% had MDR-TB 
Epidemiology of TB in Galicia
137
(n = 8), with two MDR-TB cases diagnosed per year. Detailed resistance data for 2011 is given in Table 2 .
Diagnostic delay
In symptomatic cases, the date of onset of symptoms was recorded in 70.1%; the median time until initiation of treatment was 56 days. The median patient and health care system delays were respectively 21 and 15 days. The diagnostic delay in PTB and smearpositive PTB cases was 59 and 63 days respectively, causing 37 outbreaks of TB.
Tuberculosis in vulnerable populations
The proportion of TB-HIV co-infection overall was 4.6% (n = 32), 1.5% (n = 10) among drug users. Immigrants from countries highly endemic for TB accounted for 5.2% of cases (n = 36). The evolution of TB during the period 1996-2011 in these vulnerable populations is shown in Figure 3 .
Treatment outcomes, 1996-2010
With a treatment success rate of approximately 90% in Galicia, DOT is given only in cases where nona dherence is suspected: [10] [11] [12] 38.1% (n = 299) of patients received DOT in 2010, leading to treatment success in 86.4% of patients (n = 677). Table 3 gives data and treatment outcomes for cases who began treatment in 1996-2010. Since 2000, compulsory in-patient treatment has been prescribed for 16 cases, compulsory out-patient treatment under strict supervision for 2 cases, and compulsory home isolation for 1.
Contact study
In 2011, 4742 contacts of TB patients were registered; contact investigations (tuberculin skin test [TST] and/or CXR) were carried out for 86.7% of the 
Total polyresistance (other than MDR-TB) 6 (1. smear-positive index cases. An early diagnosis was obtained for 46 new patients; 1517 were found to be infected (TST induration ⩾5 mm).
In the period 1996-2011, the number of contacts studied in order to detect either latent tuberculous infection [LTBI] or active TB disease was 134 857, of which 1552 had TB and 42 400 were infected (approximately one third per year). The percentage of patients who adhered to LTBI treatment increased in the years 1996-2010 from 57.1% in 1996 to 84.2% in 2010. Table 4 summarises the main characteristics of new TB cases diagnosed in Galicia during the period 1996-2011.
DISCUSSION
The GTPCP was created due to the high incidence of TB, and succeeded in reducing it considerably, although incidence remains higher than in many industrialised countries; 1 however, in recent years the disease has begun to reappear in some of the region's larger cities due to social problems and limitations of the existing TB control activities. 13 The reduction in the average annual TB incidence in recent years has been more pronounced in Galicia than in the WHO Europe region 14 and elsewhere in Spain, where there has been a national TB control programme since 2008. Disease control is still the responsibility of regional authorities, whose programmes are not uniform either in terms of structure or development. 15, 16 A phenomenon often observed in industrialised countries has been the decrease in the number of TB cases among the native-born population, and a reciprocal increase in foreign-born populations (United States, 17 ) . While in Spain the percentage of immigrants with newly diagnosed TB in 2010 rose to 32.7% (49.6% in Catalonia, 0.0% in Ceuta), 16 in Galicia this percentage is still very low, although there has been a simultaneous increase in the (TB-free) immigrant population that has settled in Galicia. We will need to see what 
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happens to the incoming immigrant population in future years. In line with many other studies, there is a clear predominance of males. The distribution of cases by age group is relatively uniform, a profi le that corresponds to a low-incidence country with effective disease control. 18 The high TB incidence in children is still cause for concern, and possibly results from the signifi cant diagnostic delay observed. Galicia has not been able to reduce the diagnostic delay to <30 days, 15 which is a challenge for the GTPCP as it leads to delays in treatment initiation. Reasons for diagnostic delays include delay by patients in seeking care and a lack of clinical suspicion on the part of health care professionals. The latter indicates the need for improved health education.
As in other parts of our country, in Galicia the predominant site of TB is the lung; the national average for Spain is slightly higher (74.7%), likely due to the fact that in some regions not all extra-pulmonary TB cases are notifi ed. In addition, a higher percentage of PTB patients in Galicia have cavitary images on CXR than other regions, such as Barcelona, 19 or Area 15 in the Community of Valencia; 20 this could also be related to the diagnostic delay observed.
The percentage of confi rmed new PTB cases e xceeds the goals set by the ECDC and attained by other EU/EEA countries, 14 as well as by Spain as a whole. 16 However, many areas do not collect data on DST results against fi rst-line drugs, and in Galicia the percentage of MDR-TB cases is much lower than in other regions. 8, 21 The percentage of patients with TB-HIV co-infection shows a downward trend, at <10%. TB cases among drug users and in the immigrant population did not affect the epidemiology of TB in Galicia.
Cases treated in Galicia exceed WHO 22 and EU 23 percentages of satisfactory outcomes (cure/treatment completion), which is not the case for the EU as a whole, 14 nor for neighbouring regions; this is indicative of the quality of the work of the TB surveillance and treatment team in Galicia.
In Galicia, a high percentage of contacts of smearpositive index cases are investigated, and a high proportion are recorded as having correctly completed treatment for LTBI, although in the latter case we cannot rule out underreporting, which continues to be a challenge for the GTPCP. 10 
CONCLUSION
The creation of the GTPCP has led to a reduction in TB incidence-which nevertheless remains higher than in neighbouring regions-and a fall in the average annual rate, which is again higher than the European rate. TB incidence by age group is similar to that of countries with effective TB control programmes, although the incident rate among children is still high. The long diagnostic delay possibly contributes to transmission of infection and the high incidence rate observed among children. Our study results highlight the need for effective TB programmes to control the disease. 
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